Back to search

Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo Dedifferentiation

Data up to Jan 2025

Published2005
Citations415
References46

Total Citations Per Year

Abstract

References (46)

Mutations of the BRAF gene in human cancer

2002 • 10,249 citations

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

2004 • 2,674 citations

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

2003 • 1,490 citations

Processing of gene expression data generated by quantitative real-time RT-PCR.

2002 • 1,402 citations

The RAF proteins take centre stage

2004 • 1,158 citations

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

2003 • 1,042 citations

BRAF Mutation in Papillary Thyroid Carcinoma

2003 • 915 citations

Guilty as charged

2004 • 783 citations

The Raf/MEK/ERK pathway: new concepts of activation

2001 • 716 citations

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

2003 • 671 citations

Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

1997 • 638 citations

Anaplastic thyroid carcinoma

2005 • 636 citations

Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers

2003 • 539 citations

The ins and outs of Raf kinases

1994 • 537 citations

Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996

2000 • 509 citations

Anaplastic Thyroid Carcinoma: A Study of 70 Cases

1985 • 469 citations

Raf proteins and cancer: B-Raf is identified as a mutational target

2003 • 454 citations

Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models

2001 • 441 citations

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

2003 • 424 citations

Molecular Profile and Clinical-Pathologic Features of the Follicular Variant of Papillary Thyroid Carcinoma: An Unusually High Prevalence of ras Mutations

2003 • 373 citations

BRAF mutations are associated with some histological types of papillary thyroid carcinoma

2004 • 366 citations

Molecular Profile and Clinical-Pathologic Features of the Follicular Variant of Papillary Thyroid Carcinoma

2003 • 338 citations

Levothyroxine Therapy in Patients with Thyroid Disease

1993 • 330 citations

BRAF mutations in papillary carcinomas of the thyroid

2003 • 301 citations

Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.

1996 • 292 citations

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer

2004 • 266 citations

The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.

1998 • 250 citations

One- and Two-Step Transformations of Rat Thyroid Epithelial Cells by Retroviral Oncogenes

1987 • 244 citations

Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population

2004 • 229 citations

Mice with a Mutation in the Thyroid Hormone Receptor β Gene Spontaneously Develop Thyroid Carcinoma: A Mouse Model of Thyroid Carcinogenesis

2002 • 192 citations

Long-Term Outcome of Patients With Differentiated Thyroid Carcinoma: Effect of Therapy

2000 • 190 citations

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

2004 • 176 citations

RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase

2003 • 174 citations

Molecular Mechanisms of RET Activation in Human Cancer

2002 • 171 citations

How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy

2004 • 157 citations

Improved Radioimmunoassay for Measurement of Mouse Thyrotropin in Serum: Strain Differences in Thyrotropin Concentration and Thyrotroph Sensitivity to Thyroid Hormone

1999 • 154 citations

Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid Carcinomas

2000 • 104 citations

Multiple Ras Downstream Pathways Mediate Functional Repression of the Homeobox Gene Product TTF-1

2000 • 64 citations

A Dominant Negative CREB (cAMP Response Element-Binding Protein) Isoform Inhibits Thyrocyte Growth, Thyroid-Specific Gene Expression, Differentiation, and Function

2000 • 62 citations

Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice

1999 • 61 citations

Serum Tests for Measurement of Thyroid Function

1971 • 61 citations

Hypothyroidism in Thyroid Transcription Factor 1 Haploinsufficiency Is Caused by Reduced Expression of the Thyroid-Stimulating Hormone Receptor

2003 • 60 citations

Thyroid Carcinomas in RET/PTC Transgenic Mice

1998 • 54 citations

Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes

2003 • 50 citations

Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53−/− mice

2001 • 44 citations

Gender, age, goitre type and serum TSH level predict thyroid neoplasia in 1500 patients with thyroid enlargement investigated by FNAC

2004 • 1 citations

Cited By (0)

No citing papers found in database

Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary… (2005) – Cancer Research | Metascience Observatory Explorer